NASDAQ:TCDA

Tricida, Inc.

Stock

USD

Last Close

0.11

23/01 21:00

Market Cap

5.95M

Beta: -

Volume Today

31.13M

Avg: 12.58M

PE Ratio

−0.07

PFCF: −0.08

Overview Analysis Financials Filings people Ownership API Chart Data

locale
United States
market
STOCKS
industry
Biotechnology
website
www.tricida.com
ipo date
Jun 28, 2018

Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is h...Show More

NASDAQ:TCDA

Tricida, Inc.

Last Close

0.11

23/01 21:00

Market Cap

5.95M

Beta: -

Volume Today

31.13M

Avg: 12.58M

PE Ratio

−0.07

PFCF: −0.08

locale

market

industry

website

ipo date

peer of

Earnings

Earnings per Share (Estimate*)

Revenue (Estimate*)

Metrics